Top

Journal of Neurology

Published in:

01-09-2009 | Letter to the Editors

A novel presenilin 1 mutation (L282F) in familial Alzheimer’s disease

Authors: Tsuyoshi Hamaguchi, Akiyoshi Morinaga, Tamao Tsukie, Ryozo Kuwano, Masahito Yamada

Published in: Journal of Neurology | Issue 9/2009

Excerpt

Sirs, …

Aldudo J, Bullido MJ, Arbizu T, Oliva R, Valdivieso F (1998) Identification of a novel mutation (Leu282Arg) of the human presenilin 1 gene in Alzheimr’s disease. Neurosci Lett 240:174–176. doi:10.1016/S0304-3940(97)00950-6 PubMedCrossRef

Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM (2002) Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer’s disease treatment studies. Am J Psychiatry 159:738–745. doi:10.1176/appi.ajp.159.5.738 PubMedCrossRef

Alzheimer Disease and Frontotemporal Dementia Mutation Database. Available at http://www.molgen.ua.ac.be/ADMutations/ Accessed 13 September 2008

Dermaut B, Kumar-Singh S, De Jonghe C, Cruts M, Lofgren A, Lubke U, Cras P, Dom R, De Deyn PP, Martin JJ, Van Broeckhoven C (2001) Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer’s disease due to a novel presenilin 1 mutation. Brain 124:2383–2392. doi:10.1093/brain/124.12.2383 PubMedCrossRef

Ishikawa A, Piao YS, Miyashita A, Kuwano R, Onodera O, Ohtake H, Suzuki M, Nishizawa M, Takahashi H (2005) A mutant PSEN1 causes dementia with Levy bodies and variant Alzheimer’s disease. Ann Neurol 57:429–434. doi:10.1002/ana.20393 PubMedCrossRef

McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34:939–994PubMed

Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE (1997) Matabolic reduction in the posterior cingulate cortex in very early Alzheimer’s disease. Ann Neurol 42:85–94. doi:10.1002/ana.410420114 PubMedCrossRef

Pantieri R, Pardini M, Cecconi M, Dagna-Bricarelli F, Vitali A, Piccini A, Russo R, Borghi R, Tabaton M (2005) A novel presenilin 1 L166H mutation in a pseudo-sporadic case of early-onset Alzheimer’s disease. Neurol Sci 26:349–350. doi:10.1007/s10072-005-0499-1 PubMedCrossRef

Tandon A, Rogaeva E, Mullan M, St George-Hyslop PH (2000) Molecular genetics of Alzheimer’s disease: the role of β-amyloid and the presenilins. Curr Opin Neurol 13:377–384. doi:10.1097/00019052-200008000-00003 PubMedCrossRef

10.

Tomiyama T, Nagata T, Shimada H, Teraoka R, Fukushima A, Kanemitsu H, Takuma H, Kuwano R, Imagawa M, Ataka S, Wada Y, Yoshioka E, Nishizaki T, Watanabe Y, Mori H (2008) A new amyloid β variant favoring oligomerization in Alzheimer’s-type dementia. Ann Neurol 63:377–387. doi:10.1002/ana.21321 PubMedCrossRef

Title: A novel presenilin 1 mutation (L282F) in familial Alzheimer’s disease
Authors: Tsuyoshi Hamaguchi
Akiyoshi Morinaga
Tamao Tsukie
Ryozo Kuwano
Masahito Yamada
Publication date: 01-09-2009
Publisher: D. Steinkopff-Verlag
Published in: Journal of Neurology / Issue 9/2009
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-009-5154-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

A novel presenilin 1 mutation (L282F) in familial Alzheimer’s disease

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 9/2009

Prospective study on long-term treatment with oxcarbazepine in pediatric epilepsy

Comparison of smooth pursuit eye movement deficits in multiple system atrophy and Parkinson’s disease

Clinical implications of a possible role of vitamin D in multiple sclerosis

Myopathic changes in bilateral hypertrophy of the first dorsal interosseus muscle of the hand

Negative studies that change our knowledge and attitudes

Low-dose idebenone treatment in Friedreich’s ataxia with and without cardiac hypertrophy